PCDH10 and non-small cell lung carcinoma: Future studies using larger sample sizes, including other stages of NSCLC are necessary to more comprehensively elucidate the biological effects of PCDH10 in NSCLC, and to determine whether PCDH10 methylation status provides clinical information relevant to tailored adjuvant therapy and the postoperative surveillance strategy.